1. Home
  2. IVA vs LND Comparison

IVA vs LND Comparison

Compare IVA & LND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • LND
  • Stock Information
  • Founded
  • IVA 2011
  • LND 2005
  • Country
  • IVA France
  • LND Brazil
  • Employees
  • IVA N/A
  • LND N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • LND Farming/Seeds/Milling
  • Sector
  • IVA Health Care
  • LND Consumer Staples
  • Exchange
  • IVA Nasdaq
  • LND Nasdaq
  • Market Cap
  • IVA 359.6M
  • LND 375.6M
  • IPO Year
  • IVA 2020
  • LND 2006
  • Fundamental
  • Price
  • IVA $5.32
  • LND $4.01
  • Analyst Decision
  • IVA Strong Buy
  • LND
  • Analyst Count
  • IVA 6
  • LND 0
  • Target Price
  • IVA $15.33
  • LND N/A
  • AVG Volume (30 Days)
  • IVA 71.1K
  • LND 33.1K
  • Earning Date
  • IVA 09-26-2025
  • LND 11-05-2025
  • Dividend Yield
  • IVA N/A
  • LND 6.23%
  • EPS Growth
  • IVA N/A
  • LND N/A
  • EPS
  • IVA N/A
  • LND 0.25
  • Revenue
  • IVA $14,591,573.00
  • LND $194,084,753.00
  • Revenue This Year
  • IVA $80.35
  • LND $55.76
  • Revenue Next Year
  • IVA N/A
  • LND N/A
  • P/E Ratio
  • IVA N/A
  • LND $15.18
  • Revenue Growth
  • IVA N/A
  • LND 3.73
  • 52 Week Low
  • IVA $1.53
  • LND $3.49
  • 52 Week High
  • IVA $6.50
  • LND $4.97
  • Technical
  • Relative Strength Index (RSI)
  • IVA 58.63
  • LND 67.19
  • Support Level
  • IVA $5.27
  • LND $3.90
  • Resistance Level
  • IVA $5.75
  • LND $3.99
  • Average True Range (ATR)
  • IVA 0.39
  • LND 0.07
  • MACD
  • IVA 0.03
  • LND 0.02
  • Stochastic Oscillator
  • IVA 50.66
  • LND 99.65

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

Share on Social Networks: